Author

Clara Delaunay

Institutions: Novartis (Switzerland), Novartis Institutes for BioMedical Research

Observed institutions: Novartis (Switzerland), Novartis Institutes for BioMedical Research, University of Warsaw

ORCID: 0000-0001-9478-4536

Observed ORCID: 0000-0001-9478-4536

OpenAlex ID: A5087314958

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

2017 · E. Robert McDonald, Antoine de Weck, et al. · Cell · 665

Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

2024 · Emilie A. Chapeau, Laurent Sansregret, et al. · Nature Cancer · 181

The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity

2013 · Chrysiis Michaloglou, Waltraut Lehmann, et al. · PLoS ONE · 95

Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ

2017 · Yannick Mesrouze, Marco Meyerhofer, et al. · Protein Science · 71

Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD

2017 · Yannick Mesrouze, Fedir Bokhovchuk, et al. · eLife · 60

Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors

2019 · Fedir Bokhovchuk, Yannick Mesrouze, et al. · Protein Science · 38

A Uniform Benchmark for Testing SsrA-Derived Degrons in the Escherichia coli ClpXP Degradation Pathway

2021 · Maria Magdalena Klimecka, Anna Antosiewicz, et al. · Molecules · 14

Author Correction: Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

2024 · Emilie A. Chapeau, Laurent Sansregret, et al. · Nature Cancer · 11

Author response: Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD

2017 · Yannick Mesrouze, Fedir Bokhovchuk, et al. · eLife

Works count: 9

Citation count: 1,135

H-index: 8

I10-index: 8